Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protective Effect of Ulinastatin and Thymosin α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA XI)

NCT06966687 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.

NCT NCT06966687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06966687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protective Effect of Ulinastatin and Thymosin α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA XI)
Lead sponsor
Nanjing Medical University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
April 1, 2025
Completion date
December 31, 2026
Enrollment
200 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

aortic dissection, aortic dissection aneurysm